My current research studies dysregulated ion channels and receptors in metabolic syndromes such as obesity and type 2 diabetes. I am an Associate Research Scientist at the Life Sciences Institute and the Director of Research and Training for High Throughput (HTP) Ion Channel Screening at the Center for Chemical Genomics. I have extensive experience in ion channel physiology, with specific training in studies of the molecular and functional aspects of channelopathies. HTP screening is essential in the context of metabolic disorders because it enables the efficient identification of potential therapeutic compounds, accelerates drug discovery, and provides valuable insights into disease mechanisms. This approach holds promise for developing targeted treatments and improving the quality of life for individuals with these disorders.